CytomX Therapeutics Cash from Operations (TTM) Analysis

CytomX Therapeutics Inc (CTMX)

5.10 +3.46 (+211.93%) USD | NASDAQ | May 01, 16:00

4.85 -0.25 (-4.90%) After-Hours: 18:29

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-56.04M
September 30, 2023	-35.46M
June 30, 2023	-51.07M
March 31, 2023	-60.13M
December 31, 2022	-110.79M
September 30, 2022	-140.59M
June 30, 2022	-136.44M
March 31, 2022	-130.40M
December 31, 2021	-119.03M
September 30, 2021	-105.27M
June 30, 2021	-100.24M
March 31, 2021	25.06M
December 31, 2020	5.259M
September 30, 2020	-6.793M
June 30, 2020	-5.434M
March 31, 2020	-151.19M
December 31, 2019	-140.48M

Date	Value
September 30, 2019	-139.74M
June 30, 2019	-121.98M
March 31, 2019	-99.94M
December 31, 2018	-75.52M
September 30, 2018	-24.78M
June 30, 2018	-24.96M
March 31, 2018	174.85M
December 31, 2017	170.37M
September 30, 2017	150.31M
June 30, 2017	141.86M
March 31, 2017	-15.58M
December 31, 2016	-2.032M
September 30, 2016	-12.14M
June 30, 2016	-5.721M
March 31, 2016	-27.59M
December 31, 2015	-27.42M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-151.19M

Minimum

Mar 2020

25.06M

Maximum

Mar 2021

-83.20M

Average

-105.27M

Median

Sep 2021

Cash from Operations (TTM) Benchmarks